BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1639 related articles for article (PubMed ID: 28977794)

  • 21. MAPK signaling pathways and HDAC3 activity are disrupted during differentiation of emerin-null myogenic progenitor cells.
    Collins CM; Ellis JA; Holaska JM
    Dis Model Mech; 2017 Apr; 10(4):385-397. PubMed ID: 28188262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expressions and Regulatory Effects of P38/ERK/JNK Mapks in the Adipogenic Trans-Differentiation of C2C12 Myoblasts.
    Qi R; Liu H; Wang Q; Wang J; Yang F; Long D; Huang J
    Cell Physiol Biochem; 2017; 44(6):2467-2475. PubMed ID: 29268268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway.
    Hu W; Li F; Mahavadi S; Murthy KS
    Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1310-20. PubMed ID: 19369446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
    Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA
    Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of PI3K/p70 S6K and p38 MAPK cascades increases osteoblastic differentiation induced by BMP-2.
    Viñals F; López-Rovira T; Rosa JL; Ventura F
    FEBS Lett; 2002 Jan; 510(1-2):99-104. PubMed ID: 11755539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EphrinA/EphA signal facilitates insulin-like growth factor-I-induced myogenic differentiation through suppression of the Ras/extracellular signal-regulated kinase 1/2 cascade in myoblast cell lines.
    Minami M; Koyama T; Wakayama Y; Fukuhara S; Mochizuki N
    Mol Biol Cell; 2011 Sep; 22(18):3508-19. PubMed ID: 21795402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Insulin promotes proliferation of skeletal myoblast cells through PI3K/Akt and MEK/ERK pathways in rats].
    Yu H; Zhang M; Zhao Y; Wu P; Chen PL; Li WD
    Sheng Li Xue Bao; 2013 Feb; 65(1):19-25. PubMed ID: 23426509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular Networks of the PI3K/AKT and MAPK Pathways for Regulating Toxoplasma gondii-Induced IL-23 and IL-12 Production in Human THP-1 Cells.
    Quan JH; Chu JQ; Kwon J; Choi IW; Ismail HA; Zhou W; Cha GH; Zhou Y; Yuk JM; Jo EK; Lee YH
    PLoS One; 2015; 10(11):e0141550. PubMed ID: 26528819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lactoferrin promotes murine C2C12 myoblast proliferation and differentiation and myotube hypertrophy.
    Kitakaze T; Oshimo M; Kobayashi Y; Ryu M; Suzuki YA; Inui H; Harada N; Yamaji R
    Mol Med Rep; 2018 Apr; 17(4):5912-5920. PubMed ID: 29436684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein O-fucosyltransferase 1 promotes trophoblast cell proliferation through activation of MAPK and PI3K/Akt signaling pathways.
    Liu C; Liang X; Wang J; Zheng Q; Zhao Y; Khan MN; Liu S; Yan Q
    Biomed Pharmacother; 2017 Apr; 88():95-101. PubMed ID: 28103512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK.
    Riuzzi F; Sorci G; Donato R
    J Cell Physiol; 2006 May; 207(2):461-70. PubMed ID: 16419039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of interleukin-8 secretion and activation of ERK1/2, p38 MAPK signaling pathways by thrombin in dermal fibroblasts.
    Wang L; Luo J; Fu Y; He S
    Int J Biochem Cell Biol; 2006; 38(9):1571-83. PubMed ID: 16697690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activin A stimulates the proliferation and differentiation of cardiac fibroblasts via the ERK1/2 and p38-MAPK pathways.
    Hu J; Wang X; Wei SM; Tang YH; Zhou Q; Huang CX
    Eur J Pharmacol; 2016 Oct; 789():319-327. PubMed ID: 27477354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VEGFB Promotes Myoblasts Proliferation and Differentiation through VEGFR1-PI3K/Akt Signaling Pathway.
    Ling M; Quan L; Lai X; Lang L; Li F; Yang X; Fu Y; Feng S; Yi X; Zhu C; Gao P; Zhu X; Wang L; Shu G; Jiang Q; Wang S
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L6 myoblast differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathway.
    Sarker KP; Lee KY
    Oncogene; 2004 Aug; 23(36):6064-70. PubMed ID: 15208659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of phosphatidyl inositol 3-kinase, extracellular signal-regulated kinases 1/2, and p38 mitogen-activated protein kinase inhibition on osteogenic differentiation of muscle-derived stem cells.
    Payne KA; Meszaros LB; Phillippi JA; Huard J
    Tissue Eng Part A; 2010 Dec; 16(12):3647-55. PubMed ID: 20617875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ERK1/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-kappaB transactivation during oxidative stress in skeletal myoblasts.
    Kefaloyianni E; Gaitanaki C; Beis I
    Cell Signal; 2006 Dec; 18(12):2238-51. PubMed ID: 16806820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression.
    Yang W; Chen Y; Zhang Y; Wang X; Yang N; Zhu D
    Cancer Res; 2006 Feb; 66(3):1320-6. PubMed ID: 16452185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Netrin-1 induces the migration of Schwann cells via p38 MAPK and PI3K-Akt signaling pathway mediated by the UNC5B receptor.
    Lv J; Sun X; Ma J; Ma X; Zhang Y; Li F; Li Y; Zhao Z
    Biochem Biophys Res Commun; 2015 Aug; 464(1):263-8. PubMed ID: 26116534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A specific oligodeoxynucleotide promotes the differentiation of osteoblasts via ERK and p38 MAPK pathways.
    Hou X; Shen Y; Zhang C; Zhang L; Qin Y; Yu Y; Wang L; Sun X
    Int J Mol Sci; 2012; 13(7):7902-7914. PubMed ID: 22942680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 82.